Improving Patient-reported Outcomes After Lung Cancer Surgery With Mobile Internet Platform

NCT06483295 | Recruiting

• 1 other identifier: ShanghaiChestPRO
• Study Type: interventional
• Target: 216
• Locations: 1 country
• Sites: 1

Brief Summary

This study focuses on the significant impact of lung cancer in China, highlighted by its high incidence and mortality rates, influenced by factors like aging populations, smoking, and environmental issues. It emphasizes the importance of understanding the duration, severity, and factors affecting post-surgery symptoms like pain and coughing in patients. The research underlines the value of patient-reported outcomes (PROs) in enhancing postoperative care and survival rates through improved symptom monitoring and patient engagement. Utilizing internet technology, specifically a platform integrated with WeChat, the study aims to improve patient management and follow-ups post-discharge. The objective is to use mobile internet technology to build a high-quality prospective database on postoperative lung cancer patient outcomes, analyzing factors affecting postoperative discomfort and assessing the role of interactive platforms in improving patient care.

Conditions

Lung Cancer

Keywords

patient-reported outcomes; Internet

Outcome Measures

Primary Outcomes (1)

• complaints of discomfort

  MDASI-LC score for complaints of discomfort at postoperative months 1, 3 and 4 Postoperative discomfort chief complaint MDASI-LC score: Choose a number from 0 (asymptomatic) to 10 (the most severe level imaginable) for each item to indicate the severity of the symptoms. The main complaints of postoperative discomfort include: pain, cough, shortness of breath (key points) Other factors include fatigue, nausea, insomnia, depression, memory loss, loss of appetite, drowsiness, dry mouth, sadness, vomiting, numbness or stinging wounds, constipation, etc

  4 months

Secondary Outcomes (4)

• Life quality

  4 months

• Pulmonary function-the absolute value of FEV1

  4 months

• Pulmonary function-the percentage of FEV1 to expected values

  4 months

• Change of breath sounds

  4 months

Study Arms (2)

Group A

EXPERIMENTAL

Mobile Internet Platform Follow-up Group

Other: Using mobile internet platforms for follow-up management of postoperative symptoms in lung cancer patients.

Group B

NO INTERVENTION

Traditional Outpatient Follow-up Group

Interventions

Using mobile internet platforms for follow-up management of postoperative symptoms in lung cancer patients. OTHER

Using mobile internet platforms for follow-up management of postoperative symptoms in lung cancer patients.

Group A

Eligibility Criteria

• Age: 18 Years - 80 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Diagnosed with Stage I-III lung cancer and surgically resected at our centre.
• Owns and uses a smartphone and can use WeChat.
• Volunteer to participate in this study and sign an informed consent form.

You may not qualify if:

• Received any non-surgical anti-tumour therapy (radiotherapy, chemotherapy, targeted therapy or immunotherapy) for lung cancer during the follow-up period.
• After enrolment, preoperative emergence of serious comorbidities (inability to tolerate surgery or anaesthesia) that are not suitable for, or cannot be implemented as planned, in the study's treatment regimen.
• After admission, the patient's condition changes and the need to change from elective surgery to emergency surgery is confirmed by the doctor in charge.
• At any stage after entering the study, the patient voluntarily requests to withdraw or discontinue treatment due to personal reasons.

Sponsors & Collaborators

• Shanghai Chest Hospital: lead

Study Sites (1)

Zuodong Song

Shanghai, Shanghai Municipality, 200030, China

RECRUITING

Related Publications (1)

• Luo Y, Cheng Y, Song Z, Chen H, Bo Y, Shixing H. Patient-reported outcomes with a personalized follow-up program after lung cancer resection: A single-center randomized controlled trial. Asia Pac J Oncol Nurs. 2026 Jan 2;13:100844. doi: 10.1016/j.apjon.2025.100844. eCollection 2026 Dec.

  PMID: 41625083 DERIVED

MeSH Terms

Conditions

Lung Neoplasms

Condition Hierarchy (Ancestors)

Respiratory Tract Neoplasms; Thoracic Neoplasms; Neoplasms by Site; Neoplasms; Lung Diseases; Respiratory Tract Diseases

Study Officials

• Xinghua Cheng, MD

  Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Xinghua Cheng, MD

CONTACT

+8617701681215; chengxinghua_001@163.com

Xinghua Cheng

CONTACT

+8617701681215; chengxinghua_001@163.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Director, Head of Oncology Surgery, Clinical Professor

Study Record Dates

• First Submitted: March 13, 2024
• First Posted: July 3, 2024
• Study Start: March 24, 2024
• Primary Completion: July 7, 2024
• Study Completion (Estimated): December 31, 2026
• Last Updated: May 28, 2025

Record last verified: 2025-05

Locations

CN (1)